# Mood Stabilizer-induced Metabolic Abnormalities in Bipolar Disorder

> **NCT04486092** · NA · UNKNOWN · sponsor: **National Cheng-Kung University Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** Valproic Acid

## Key facts

- **NCT ID:** NCT04486092
- **Lead sponsor:** National Cheng-Kung University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-02
- **Primary completion:** 2021-07
- **Final completion:** 2021-07
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2020-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04486092

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04486092, "Mood Stabilizer-induced Metabolic Abnormalities in Bipolar Disorder". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04486092. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*